Parental hyperdynamic circulation predicts insulin resistance in offspring: The Tecumseh Offspring Study

Hypertension

Volumn 33, Issue 3, 1999, Pages 769-774

  Palatini, Paolo ^a   Vriz, Olga ^a   Nesbitt, Shawna ^b   Amerena, John ^b   Majahalme, Silja ^b   Valentini, Mariaconsuelo ^b   Julius, Stevo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Heart rate; Hemodynamics; Hypertension; Insulin; Obesity; Sympathetic tone

Indexed keywords

ADRENALIN; INSULIN;

ADOLESCENT; ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CHILD; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART INDEX; HEART MUSCLE CONTRACTILITY; HEART STROKE VOLUME; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MOTHER CHILD RELATION; PRIORITY JOURNAL; PROGENY; TACHYCARDIA;

EID: 0033037875     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.3.769     Document Type: Article

References (32)

1. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med.1987;317:350-357.
2. Stern MP, Morales PA, Haffner SM, Valdez RA. Hyperdynamic circulation and the insulin resistance syndrome ("Syndrome X"). Hypertension. 1992;20:802-808.
3. Xiaozhang J, Srinavasan SR, Urbina E, Berenson GS. Hyperdynamic circulation and cardiovascular risk in children and adolescents. Circulation. 1995;91:1101-1106.
4. Bao W, Srinavasan SR, Wattigney WA, Berenson GS. The relation of parental cardiovascular disease to risk factors in children and young adults: the Bogalusa Heart Study. Circulation. 1995;91:365-371.
5. Charles MA, Pettitt DJ, Hanson RL, Bennette PH, Saad MF, Liu QZ, Knowler WC. Familial and metabolic factors related to blood pressure in Pima Indian children. Am J Epidemiol. 1994;140:123-131.
6. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens. 1989;2(suppl 3, pt 2):125S-132S.
7. Landsberg L. Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension. 1992;19:161-166.
8. Krieger DR, Landsberg L. Obesity and hypertension. In: Laragh JH, Brenner BM, eds. Hypertension. New York, NY: Raven Press; 1995: 2367-2388.
9. Julius S, Krause L, Schork N, Mejia A, Jones K, van de Yen C, Johnson EH, Sekkarie MA, Kjeldsen SE, Petrin J, Schmouder R, Gupta R, Ferraro J, Nazzaro P, Weissfeld J. Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens. 1991;9:77-84.
10. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens. 1994;12: 495-502.
11. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension. 1997;30:1267-1273.
12. Julius S, Jamerson K, Mejia A, Krause L, Schork N, Jones K. The association of borderline hypertension with target organ changes and higher coronary risk: Tecumseh Blood Pressure Study. JAMA. 1990;264: 354-358.
13. Jamerson K, Schork N, Julius S. Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure: the Tecumseh Blood Pressure Study. Hypertension. 1992;20:314-318.
14. Annest JL, Sing CF, Biron P. Familial aggregation of blood pressure and weight in adoptive families, III: analysis of the role of shared genes and shared household environment in explaining family resemblance for height, weight and selected weight/height indices. Am J Epidemiol. 1983; 117:492-506.
15. Julius S, Randall OS, Esler MD, Kashima T, Ellis CN, Bennett J. Altered cardiac responsiveness and regulation in the normal cardiac output type of borderline hypertension. Circ Res. 1975;36/37(suppl I):I199-I207.
16. Kjeldsen SE, Zweifler AJ, Petrin J, Weder AB, Julius S. Sympathetic. nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased β-adrenoreceptor responsiveness. Blood Press. 1994;3:164-171.
17. Trimarco B, Volpe M, Ricciardelli B, Picotti GB, Galva MA, Petracca R. Studies of the mechanisms underlying impairment of beta-adrenoreceptor-mediated effects in human hypertension. Hypertension. 1983;5: 584-590.
18. Bertel O, Buhler F, Kiowski W, Lutold BE. Decreased beta-adrenoreceptor responsiveness is related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension. 1980;2: 130-138.
19. Julius S, Conway J. Hemodynamic studies in patients with borderline blood pressure elevation. Circulation. 1968;38:282-288.
20. Julius S, Egan B. Hemodynamics of hypertension. In: Zanchetti A, Tarazi RC, eds. Handbook of Hypertension. Vol 7: Pathophysiology of Hypertension-Cardiovascular Aspects. Amsterdam, Netherlands: Elsevier Science Publishing Co Inc; 1986:153-178.
21. Blaak EE, Saris WH, van Baak MA. Adrenoreceptor subtypes mediating catecholamine-induced thermogenesis in man. InI J Obes Relat Metab Disord. 1993;17(suppl 3):S78-S81.
22. Blaak EE, van Baak MA, Kester AD, Saris WH. β-Adrenergically mediated thermogenic and heart rale responses: effect of obesity and weight loss. Metabolism. 1995;44:520-524.
23. Julius S. Corcoran lecture. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension. 1993;21(part 2):886-893.
24. Bougneres P, Stunff CL, Pecqueur C, Pinglier E, Adnot P, Ricquier D. In vivo resistance of lipolysis to epinephrine: a new feature of childhood onset obesity. J Clin Invest. 1997;99:2568-2573.
25. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger JA, Lindberg HA. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol. 1980;112:736-749.
26. Kannel WB, Wilson P, Blair SN. Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J. 1985;109:876-885.
27. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J. 1991;121:172-177.
28. Palatini P, Julius S. Heart rate and cardiovascular risk. J Hypertens. 1997;15:3-I7.
29. Kurtz TW, Gardner DG. Transcription-modulating drugs: a new frontier in the treatment of essential hypertension. Hypertension. 1998;32: 380-386.
30. Volpe M, Trimarco B, Ricciardelli B, Sacca L, Ungaro B, Rengo F, Condorelli M. Effects of oral salt loading on beta-adrenergic receptor responsiveness in normal and hypertensive subjects. Cardiovasc Res. 1982;16:732-737.
31. Kjeldsen SE, Zweifler AJ, Petrin J, Weder A, Julius S. Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoreceptor responsiveness. Blood Press. 1994;3:164-171.
32. Kjeldsen SE, Moan A, Petrin J, Weder A, Julius S. Effects of increased arterial epinephrine on insulin, glucose and phosphate. Blood Press. 1996;5:27-31.